Mediveine

Diosmin, the active ingredient in Mediveine, is a flavonoid presented as an oral dosage form for oral use. It is commonly employed to support vascular health and manage chronic venous conditions in adults. GNH USA supplies Mediveine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Diosmin is used primarily in disorders of the venous and vascular system. - Chronic venous insufficiency: improves venous tone and reduces leg swelling and pain. - Hemorrhoidal disease: lessens bleeding, discomfort and inflammation of hemorrhoids. - Lymphatic edema: supports lymphatic drainage and decreases fluid accumulation in affected limbs.

Adverse reactions reported with oral diosmin are generally mild to moderate.

Common Side Effects: - Gastrointestinal discomfort: nausea, abdominal pain or dyspepsia. - Headache. - Dizziness. - Skin rash or pruritus. - Mild flushing. - Diarrhoea.

Serious or Rare Side Effects: - Allergic reactions: urticaria, angioedema. - Anaphylaxis. - Severe skin reactions such as Stevens‑Johnson syndrome. - Hepatic dysfunction: elevated liver enzymes. - Thrombocytopenia. - Severe hypersensitivity with systemic involvement.

Before initiating therapy, consider the following safety measures. - Assess renal and hepatic function: adjust use if impairment is present. - Monitor for hypersensitivity: discontinue if allergic signs appear. - Caution in pregnancy and breastfeeding: use only if clearly needed. - Review concomitant anticoagulant or antiplatelet therapy: increased bleeding risk. - Store at room temperature below 25°C: keep in the original container, protect from moisture and light.

Diosmin may alter the effect of several medications.

Major Interactions (Avoid): - Warfarin or other vitamin K antagonists: enhanced anticoagulant effect. - Aspirin and clopidogrel: additive antiplatelet activity increasing bleeding risk. - Other flavonoid supplements: potential for synergistic adverse effects.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): monitor for gastrointestinal irritation. - Antihypertensive agents: possible additive blood pressure lowering. - Oral contraceptives: observe for altered hormonal efficacy.